Related Experiment Videos
ASO Author Reflections: The Optimal Circumferential Resection Margin in Pathological T3 Esophageal Cancer
Ryoma Haneda1, Hirotoshi Kikuchi2, Hiroya Takeuchi1
1Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Annals of Surgical Oncology
|March 6, 2022
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Clinical diagnostic accuracy and lymph node metastasis patterns in clinical T1bN0M0 esophageal squamous cell carcinoma: a supplementary analysis of JCOG1409.
Esophagus : official journal of the Japan Esophageal Society·2026
Alcohol Consumption Is a Risk Factor of Surgical Site Infection After Minimally Invasive Surgery: A Secondary Observational Analysis of a Clinical Trial.
Annals of gastroenterological surgery·2026
Development and validation of a novel perioperative risk model for anastomotic leakage after esophagectomy using a nationwide web-based database.
Esophagus : official journal of the Japan Esophageal Society·2026
Association between pretherapeutic M2BPGi levels and postoperative skeletal muscle depletion in patients with esophageal squamous cell carcinoma.
Esophagus : official journal of the Japan Esophageal Society·2026
A Spleen-Preserving Approach Using Partial Splenectomy for Pancreatic Tail Lesions: A Video Case Report.
Annals of surgical oncology·2026
The Impact of Initial Biopsy Modality and Provider Credentials on Upstaging and Management Changes in Cutaneous Melanoma.
Annals of surgical oncology·2026
Liquid Biopsy in Resected Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis.
Annals of surgical oncology·2026
Feasibility of Single-Session Whole-Liver Yttrium-90 Radioembolization for Multifocal Hepatocellular Carcinoma.
Korean journal of radiology·2026
Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Not all anti-CD38 antibodies are created equal: The epitope of felzartamab is partially DTT-resistant.
Transfusion medicine (Oxford, England)·2026